US researchers using nanotech, gene editing to turn off cholesterol gene in mice

Chicago

RESEARCHERS in the US have used nanotechnology plus the powerful CRISPR-Cas9 gene editing tool to turn off a key cholesterol-related gene in mouse liver cells, an advance that could lead to new ways to correct genes that cause high cholesterol and other liver diseases.

Nanotechnology is the design and manipulation of materials thousands of times smaller than the width of a human hair.